Pet Companies with the Potential to Become the “Novo Nordisk”, “Dexcom” or “One Medical” of Pet Healthcare – Deep-Dive into the Next Generation of Companion Animal Health Companies.
The global pet healthcare ecosystem has moved beyond pet food and e-commerce into advanced therapeutics, AI, digital veterinary care, precision diagnostics, longevity medicine and regenerative biology. Unlike the previous wave of pet startups, today’s most promising companies are building defensible intellectual property, regulated healthcare products and scalable clinical platforms.
5 Most Promising Pet Healthcare companies to watch out for, are:
1. Loyal (San Francisco, USA)
The World’s Leading Pet Longevity Company
5
Sector: Longevity therapeutics
Founded: 2019
Capital raised: Over US$250 million, including a US$100 million Series C announced in 2026.
What are they building
Loyal is developing the first FDA-approved lifespan-extension drug for dogs. Pipeline includes:
-
LOY-001
-
LOY-002
-
LOY-003
These therapies target the biological mechanisms of ageing rather than individual diseases.
Why it could become huge
If successful, Loyal will effectively create an entirely new veterinary therapeutic category. Rather than treating arthritis, heart disease or kidney disease individually, its products aim to extend healthy lifespan across multiple conditions.
Why this company has great future potential:
-
Massive unmet needs being targeted
-
Strong FDA engagement
-
First-mover advantage
-
Deep scientific moat
-
Potential blockbuster revenues
2. Modern Animal (Los Angeles, USA)
Reinventing Veterinary Hospitals
Sector: Veterinary care platform
Modern Animal has become the benchmark for digitally enabled veterinary care. Unlike traditional clinics, it combines:
-
membership subscriptions;
-
physical hospitals;
-
telemedicine;
-
AI-enabled workflows;
-
mobile-first customer engagement.
The company has reportedly achieved an annual revenue run rate of around US$100 million, making it one of the few pet healthcare startups to demonstrate meaningful operating scale.
3. Gallant (San Diego, USA)Â
Stem Cell Medicine for Pets
Sector: Regenerative medicine
Gallant is building what could become the first major stem cell therapy platform in veterinary medicine. Recent milestones include:
-
US$18 million Series B financing in 2025;
-
total funding of approximately US$44.5 million;
-
lead therapy approaching FDA review for feline chronic gingivostomatitis; and
-
pipeline expansion into osteoarthritis, chronic kidney disease and atopic dermatitis.
4. Airvet (Los Angeles, USA)
Digital Infrastructure for Veterinary Medicine
Sector: Veterinary telehealth
Airvet has evolved well beyond virtual consultations into a broader digital care platform. Services include:
-
telemedicine;
-
online pharmacy;
-
wellness programmes;
-
employer-sponsored pet health benefits;
-
specialty referrals; and
-
AI-assisted care coordination.
The company raised an additional US$11 million to accelerate expansion and continues to grow rapidly in the employee benefits market.
5. Lassie (Stockholm, Sweden)
Prevention-First Pet Insurance
Sector: Pet insurance and preventive care
Lassie is transforming pet insurance from a reimbursement business into a preventive healthcare platform. Key differentiators include:
-
AI-assisted claims processing;
-
prevention-based incentives;
-
digital health education;
-
integrated care recommendations; and
-
expansion across major European markets.
The company secured a US$75 million Series C in 2026, one of the largest recent funding rounds in European pet healthcare.
Honorable Mentions
Several other startups are worth close monitoring:
-
Digitail (Netherlands) – Cloud-native veterinary practice management software with strong international traction
-
Embark Veterinary – Consumer genetic testing and precision breeding insights for dogs
-
Petfolk (USA) – Technology-enabled veterinary clinic network
-
11Liter (South Korea) – AI-based disease detection from smartphone images.
-
Traini (USA) – AI-powered pet behavioral and emotional intelligence platform
